Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.

Tang C, Luo H, Luo D, Yang H, Zhou X

Open source

DOI
10.3892/or.2017.6109
Published
2018 Feb
Container
Oncology reports
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 19/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/or.2017.6109,
  title = {Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.},
  author = {Tang C and Luo H and Luo D and Yang H and Zhou X},
  year = {2018},
  journal = {Oncology reports},
  doi = {10.3892/or.2017.6109},
  url = {https://doi.org/10.3892/or.2017.6109}
}

RIS

TY  - JOUR
TI  - Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
AU  - Tang C
AU  - Luo H
AU  - Luo D
AU  - Yang H
AU  - Zhou X
PY  - 2018
JO  - Oncology reports
DO  - 10.3892/or.2017.6109
UR  - https://doi.org/10.3892/or.2017.6109
ER  - 

APA

C, T., H, L., D, L., H, Y., & X, Z. (2018). Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.. Oncology reports. https://doi.org/10.3892/or.2017.6109

Source records